Skip to content
Home/Companies/Healthcare/Flamingo Therapeutics
FT

Flamingo Therapeutics

Healthcare·France·Active

Flamingo Therapeutics is a healthcare company, headquartered in France.

Entry
–
Hold
–
Status
Active
Est. EV
–

Who owns Flamingo Therapeutics?

Flamingo Therapeutics is currently owned by Kurma Partners through Kurma Biofund III (2018 vintage). Across its history, Flamingo Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Kurma Partners
Most recent investor
Kurma Partners
Kurma Biofund III · 2018 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods

Active
Co-held by Andera Partners and Kurma Partners since 2018.
Andera Partners
Andera PartnersActive
2018 · present · BioDiscovery 5 · 2017 · VC
MOIC
–
Kurma Partners
Kurma PartnersActive
present · Kurma Biofund III · 2018 · VC
MOIC
–

More from Kurma Biofund III

Other portfolio companies in the same fund.

Corlieve Therapeutics
Active
HealthcareFrance
Corteria
Active
HealthcareFrance
Emergence
Active
HealthcareFrance
MedLumics
Active
HealthcareFrance
RyCarma
Active
HealthcareFrance
Synendos Therapeutics
Active
HealthcareFrance

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings